Annual Total Liabilities
$198.32 M
+$54.47 M+37.87%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual total liabilities is $198.32 million, with the most recent change of +$54.47 million (+37.87%) on December 31, 2023.
- During the last 3 years, CTNM annual total liabilities has risen by +$56.91 million (+40.24%).
- CTNM annual total liabilities is now at all-time high.
Performance
CTNM Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$5.81 M
+$1.95 M+50.73%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly total liabilities is $5.81 million, with the most recent change of +$1.95 million (+50.73%) on September 30, 2024.
- Over the past year, CTNM quarterly total liabilities has dropped by -$192.52 million (-97.07%).
- CTNM quarterly total liabilities is now -97.10% below its all-time high of $200.19 million, reached on September 30, 2023.
Performance
CTNM Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CTNM Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.9% | -97.1% |
| 3 y3 years | +40.2% | -96.0% |
| 5 y5 years | +40.2% | -96.0% |
CTNM Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.2% | -97.1% | +50.7% |
| 5 y | 5-year | at high | +40.2% | -97.1% | +50.7% |
| alltime | all time | at high | +40.2% | -97.1% | +50.7% |
Contineum Therapeutics Class A Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.81 M(+50.7%) |
| Jun 2024 | - | $3.85 M(-98.1%) |
| Mar 2024 | - | $199.19 M(+0.4%) |
| Dec 2023 | $198.32 M | $198.32 M(-0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $200.19 M(+39.2%) |
| Dec 2022 | $143.85 M(+1.7%) | - |
| Dec 2022 | - | $143.85 M |
| Dec 2021 | $141.41 M | - |
FAQ
- What is Contineum Therapeutics Class A annual total liabilities?
- What is the all time high annual total liabilities for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual total liabilities year-on-year change?
- What is Contineum Therapeutics Class A quarterly total liabilities?
- What is the all time high quarterly total liabilities for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly total liabilities year-on-year change?
What is Contineum Therapeutics Class A annual total liabilities?
The current annual total liabilities of CTNM is $198.32 M
What is the all time high annual total liabilities for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual total liabilities is $198.32 M
What is Contineum Therapeutics Class A annual total liabilities year-on-year change?
Over the past year, CTNM annual total liabilities has changed by +$54.47 M (+37.87%)
What is Contineum Therapeutics Class A quarterly total liabilities?
The current quarterly total liabilities of CTNM is $5.81 M
What is the all time high quarterly total liabilities for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly total liabilities is $200.19 M
What is Contineum Therapeutics Class A quarterly total liabilities year-on-year change?
Over the past year, CTNM quarterly total liabilities has changed by -$192.52 M (-97.07%)